MAPK1 and cancer: Kim et al. [179] reported the effect of SFN on cell growth at 72 h in OVCAR3, OVCAR4, OVCAR5, and SKOV3 cell lines and found that SFN was effective at inhibiting cancer cell growth via activation of p38 and ERK.